10-Q: RF Acquisition Corp II Q1 2026 Update

RF Acquisition Corp II reports Q1 2026 results, with net income of $93,702, driven by interest income, while continuing its search for a business combination.

Summary

• RF Acquisition Corp II filed its quarterly report for the period ending March 31, 2026.
• The company reported a net income of $93,702 for the quarter, primarily from interest earned on its trust account.
• General, administrative, and operational costs for the quarter were $360,594.
• The company continues its search for a business combination, focusing on deep technology sectors in Asia, excluding entities with China operations through a VIE structure.
• The deadline to complete a business combination has been extended to August 15, 2026.
• A business combination agreement was entered into on October 2, 2025, with Nanyang Biologics Pte. Ltd. (Nanyang) via a merger with NYB Holdings Limited (PubCo).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as neutral to slightly negative due to the ongoing uncertainty of a business combination and the identified substantial doubt about the company's ability to continue as a going concern, despite progress in extending deadlines and securing a business combination agreement.

Positives

• Generated net income of $93,702 for the quarter, an improvement from the prior year's net income of $1,020,970, though this is primarily due to interest income.
• Successfully extended the deadline to complete a business combination to August 15, 2026, providing more time to identify and finalize a deal.
• Maintained a significant balance in the trust account ($52,891,674 as of March 31, 2026) to support potential redemptions and future operations.
• Entered into a Business Combination Agreement with Nanyang Biologics Pte. Ltd., indicating progress towards a potential merger.

Negatives

• Incurred significant general, administrative, and operational costs of $360,594 for the quarter, with no operating revenue generated.
• The company has a working capital deficit of $928,243 as of March 31, 2026.
• Management has determined that conditions raise substantial doubt about the company's ability to continue as a going concern within one year.
• A significant number of public shares (4,831,265) are subject to possible redemption, which could impact available funds.
• Disclosure controls and procedures were found to be not effective at a reasonable assurance level.

Risks

• The company has not commenced any operations and will not generate operating revenues until after the completion of a business combination.
• There is no assurance that the company will be able to successfully effect a business combination.
• If a business combination is not completed within the Combination Period (August 15, 2026), the company will cease operations, redeem all public shares, and liquidate.
• The company's ability to continue as a going concern is subject to substantial doubt due to its lack of operations, reliance on future financing, and the potential for share redemptions.
• Geopolitical instability, including the Russia-Ukraine conflict and the Israel-Hamas conflict, could adversely affect the company's search for a business combination and any target business.

Future Outlook

The company is actively seeking a business combination and has extended its deadline to August 15, 2026. The company's future operations and financial condition are contingent upon the successful completion of a business combination. Management has identified substantial doubt about the company's ability to continue as a going concern within one year.

Management Comments

• Management has determined that the conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the unaudited financial statements are issued.
• Management intends to implement remediation steps to improve our disclosure controls and procedures and our internal control over financial reporting.
• We intend to pursue a Business Combination with a target in any industry that can benefit from the expertise and capabilities of our Management Team.

Industry Context

StockSavvy.ai notes that RF Acquisition Corp II operates as a Special Purpose Acquisition Company (SPAC), a common vehicle for taking private companies public. The company's focus on deep technology sectors in Asia aligns with current investment trends, but the extended timeline and ongoing search for a target are typical challenges faced by SPACs.

Comparison to Industry Standards

• As a SPAC, direct comparison to operating companies is not applicable. However, the company's trust account balance of $52.9 million as of March 31, 2026, is a key metric for its ability to complete a business combination and fund potential redemptions.
• The extension of the combination deadline to August 15, 2026, is within the typical range for SPACs that require additional time to identify and negotiate a suitable target.
• The net income of $93,702 for the quarter is solely derived from interest income on the trust account, which is standard for SPACs prior to a business combination.

Corporate Governance

Legal Proceedings

• None reported.

Related Party Transactions

• Advance from related party (Sponsor) of $138,550 as of March 31, 2026.
• Due to Sponsor balance of $250,725 as of March 31, 2026, mainly for administration fees.
• Sponsor charges an administrative fee of up to $10,000 per month for office space, utilities, and administrative support.
• Sponsor and EBC purchased Private Placement Units in connection with the Initial Public Offering and over-allotment exercise.
• Sponsor received Founder Shares in exchange for operating costs borne by the Company.

Stakeholder Impact

• Shareholders: Potential redemption of shares if a business combination is not completed; potential dilution if new shares are issued as part of a business combination; potential value creation or loss depending on the success of the business combination.
• Creditors: The company has minimal liabilities, but its ability to meet obligations depends on the successful completion of a business combination or liquidation.
• Sponsor and Management: Their compensation and returns are tied to the successful completion of a business combination and the subsequent performance of the combined entity.

Next Steps

• Continue the search for and negotiation of a business combination.
• Complete the business combination with Nanyang Biologics Pte. Ltd. by August 15, 2026.
• Implement remediation steps to improve disclosure controls and procedures and internal control over financial reporting.

Key Dates

Recommendation

The company is a SPAC with an identified target and an extended deadline, but significant uncertainties remain regarding the completion of the business combination and its going concern status. Investors should hold positions pending further clarity on the business combination and its terms.

Keywords

RF Acquisition Corp II, SPAC, 10-Q, Quarterly Report, Business Combination, Nanyang Biologics, Trust Account, Emerging Growth Company, Financial Statements, SEC Filing